INHIBITION
OF
PSEUDOMONAS
AERUGINOSA
BY
ASCORBIC
ACID
ACTING
SINGLY
AND
IN
COMBINATION
WITH
ANTIMICROBIALS
INVITRO
AND
INVIVO
STUDIES
ASCORBIC
ACID
ACTING
ON
ITS
OWN
IS
FOUND
TO
EXERT
A
BACTERIOSTATIC
ACTION
IN
VITRO
ON
16
STRAINS
OF
PSEUDOMONAS
AERUGINOSA
TESTED
THIS
ACTION
ATTRIBUTABLE
TO
THE
OXIDATION
OF
ASCORBIC
ACID
IS
DEPENDENT
ON
INDIVIDUAL
STRAINS
AND
THE
INOCULUM
SIZE
IN
COMBINATION
WITH
SULPHAMETHOXAZOLE
TRIMETHOPRIM
SEPTRIN
AMPICILLIN
ERYTHROMYCIN
CHLORAMPHENICOL
OR
COLISTIN
SULPHATE
ASCORBIC
ACID
ACTS
SYNERGISTICALLY
ON
PSEUDOMONAS
AERUGINOSA
IN
VITRO
EXPERIMENTS
IN
MICE
WITH
ERYTHROMYCINASCORBIC
ACID
COMBINATION
SHOW
THAT
THE
CURVATIVE
DOSE
50
OF
ASCORBIC
ACID
ACTING
ALONE
IS
1122
MILLIGRAMMES
PER
KILOGRAM
BODY
WEIGHT
THIS
WAS
SIGNIFICANTLY
LOWERED
P

0001
TO
691
MGKG
IF
ADMINISTERED
IN
COMBINATION
WITH
ERYTHROMYCIN
10
MGKG
IN
HUMAN
PATIENTS
WITH
CYSTIC
FIBROSIS
BY
THE
COMBINED
ADMINISTRATION
OF
ASCORBIC
ACID
SULPHAMETHOXAZOLE
AND
TRIMETHOPRIM
BACTRIM
ROCHE
THE
PSEUDOMONAS
INFECTION
COULD
BE
CONTROLLED
AS
THE
VIABLE
NUMBER
OF
ORGANISMS
SIGNIFICANTLY
DIMINISHED
DURING
THE
THERAPY
